Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds HILS.
No tracked institution reports a position in HILS as of their last filing.
No one on the platform has traded HILS yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| HILSHillstream BioPharma, Inc. | $0.24 | +5.66% | $4M | — |
| APTOAptose Biosciences Inc. | $1.71 | +100.00% | $4M | — |
| BCELAtreca, Inc. | $0.09 | -1.32% | $4M | — |
| CYTOAltamira Therapeutics Ltd. | $0.30 | +100.00% | $1M | — |
| GMDAGamida Cell Ltd. | $0.03 | +0.00% | $4M | — |
| GRTSGritstone bio, Inc. | $0.03 | -31.78% | $4M | — |
| NBRVFNabriva Therapeutics plc | $0.00 | +0.00% | $323 | — |
Source: Financial Modeling Prep · peers by sector/industry